Skip to content

Marchex MCHX Proceeds from exercises of stock options and other stock issuances

Proceeds from exercises of stock options and other stock issuances at other companies

HubSpot logo
HubSpotHUBS
Five9 logo
Five9FIVN
Doximity logo
DoximityDOCS

Other financials

Income statement

See full
Revenue$10.6M-6.9%
Gross profit$6.5M-9.9%
Operating income-$1.4M+27.8%
Net income-$1.7M+13.0%
EPS (diluted)-$0.04+20.0%

Balance sheet

See full
Cash & equivalents$9.0M-10.0%
Total debt$578.0K-58.4%
Total equity$28.9M-8.0%
Total assets$38.5M-5.1%

Cash flow

See full
Operating cash flow-$514.0K+80.4%
CapEx$5.0K-95.8%
Free cash flow-$361.0K

Valuation

See full
Market cap$71.33M-24.8%
Enterprise value$62.89M-26.4%
P/S1.6×-0.4×

Profitability

See full
Gross margin62.9%-1.8pp
Operating margin-11.7%+1.6pp
Net margin-11.1%-0.3pp
FCF margin-3.2%

Returns & leverage

See full
Return on equity-16.5%0.0pp
Debt / equity0.0×
Current ratio2.2×-0.3×

Where this comes from

Reported directly by Marchex in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Marchex’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Marchex's proceeds from exercises of stock options and other stock issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Marchex's proceeds from exercises of stock options and other stock issuances?
Marchex (MCHX) reported proceeds from exercises of stock options and other stock issuances of $2K in Q1 2026.
How has Marchex's proceeds from exercises of stock options and other stock issuances changed year-over-year?
Marchex's proceeds from exercises of stock options and other stock issuances decreased by 99.3% year-over-year, from $268K to $2K.
What is the long-term trend for Marchex's proceeds from exercises of stock options and other stock issuances?
Over 4 years (2021 to 2025), Marchex's proceeds from exercises of stock options and other stock issuances has grown at a -13.2% compound annual growth rate (CAGR), from $528K to $300K.